SAMHSA extends methadone take-home flexibilities initiated during pandemic
The Substance Abuse and Mental Health Services Administration yesterday extended certain methadone take-home flexibilities for opioid treatment programs until one year after the end of the COVID-19 public health emergency, and said it is considering ways to make the flexibilities permanent.
SAMHSA in 2020 allowed states to request a blanket exception to allow stable patients in an opioid treatment program to receive 28 days of take-home doses of their OUD medication, and other eligible patients to receive up to 14 days of take-home medication, which the agency said has enhanced and encouraged use of treatment services.
Related News Articles
Headline
President Biden March 13 announced the White House Challenge to Save Lives from Overdose, a national call to action for the public and private sectors to…
Headline
Released during National Eating Disorder Awareness week, the latest AHA People Matter, Words Matter poster encourages compassionate and caring language when…
Headline
The Substance Abuse and Mental Health Services Administration Feb. 8 issued a final rule implementing Coronavirus Aid, Relief, and Economic Security Act…
Headline
The Substance Abuse and Mental Health Services Administration Jan. 31 updated its Overdose Prevention and Response Toolkit, which includes basic information on…
Headline
The Substance Abuse and Mental Health Services Administration Jan. 31 issued a final rule that updates certain regulations for Opioid Treatment Programs and…
Headline
The House Dec. 12 voted 386-37 to pass AHA-supported legislation (H.R. 4531) that would reauthorize key SUPPORT Act programs for patients with substance use…